Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1975 May 17;2(5967):360-2.
doi: 10.1136/bmj.2.5967.360.

Atropine, sodium cromoglycate, and thymoxamine in PGF2 alpha-induced bronchoconstriction in extrinsic asthma

Clinical Trial

Atropine, sodium cromoglycate, and thymoxamine in PGF2 alpha-induced bronchoconstriction in extrinsic asthma

K R Patel. Br Med J. .

Abstract

In six patients with extrinsic bronchial asthma the inhalation of prostaglandin (PG) F2 alpha in a small dosage produced significant bronchoconstriction, whereas PGE2 produced bronchodilatation. In these patients cholinergic blockade with atropine partially inhibited the PGF2 alpha-induced bronchoconstriction, but the alpha-receptor-blocking drug thymoxamine and sodium cromoglycate did not. These results suggest that the effect of PGF2 alpha is mediated through cholinergic receptors in the airways, and this effect is grossly exaggerated in asthma. The failure to inhibit PGF2 alpha-induced bronchoconstriction with sodium cromoglycate and the observation of an inhibitory effect of sodium cromoglycate in both allergic and exercise asthma suggest that locally formed PGF2 alpha may not be the main factor in the pathogenesis of bronchial asthma.

PubMed Disclaimer

References

    1. Br J Pharmacol Chemother. 1967;31:340-4 - PubMed
    1. J Clin Invest. 1956 Mar;35(3):327-35 - PubMed
    1. Acta Allergol Suppl (Copenh). 1958;5:187-221 - PubMed
    1. Lancet. 1974 Dec 14;2(7894):1419-21 - PubMed
    1. Clin Allergy. 1974 Sep;4(3):311-22 - PubMed

Publication types

MeSH terms

LinkOut - more resources